section name header

Pronunciation

SOE-dee-um bye-KAR-boe-nate

Classifications

Therapeutic Classification: antiulcer agents

Pharmacologic Classification: alkalinizing agents

Indications

REMS

Unlabeled Uses:

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Following oral administration, excess bicarbonate is absorbed and results in metabolic alkalosis and alkaline urine. IV administration results in complete bioavailability.

Distribution: Widely distributed into extracellular fluid.

Metabolism/Excretion: Sodium and bicarbonate are excreted by the kidneys.

Half-life: Unknown.

Time/Action Profile

(PO = antacid effect; IV = alkalinization)

ROUTEONSETPEAKDURATION
POimmediate30 min1–3 hr
IVimmediaterapidunknown

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: edema.

F and E: metabolic alkalosis, hypernatremia, hypocalcemia, hypokalemia.

GI: PO: flatulence, gastric distention.

Local: irritation at IV site.

Neuro: cerebral hemorrhage (with rapid injection in infants), tetany.

Interactions

Drug-Drug:

Route/Dosage

see Calculator

Contains 12 mEq of sodium/g

Alkalinization of Urine

Antacid

Systemic Alkalinization/Cardiac Arrest

Renal Tubular Acidosis

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes